Two new studies suggest that Parkinson's disease can potentially be treated with stem cells placed in a patient's brain.

Two early-phase clinical trials demonstrate the safety and potential clinical utility of stem cell therapies to ease motor ...

Two independent clinical trials demonstrate the safety of stem cell therapies for Parkinson's disease. The papers, published ...

Glycolysis is an ancient metabolic activity. It consists of a set of reactions that convert glucose into energy. This central ...

A stem cell–based therapy initially developed at Memorial Sloan Kettering Cancer Center (MSK) may lead to a new treatment for advanced Parkinson's disease, according to results from a phase 1 clinical ...

The studies also ‘offer hope’ that transplanted cells could tackle symptoms of the condition, such as tremors.

known as human-induced pluripotent stem cells, are typically adult skin or blood cells that have been reprogrammed in a lab to become like embryonic stem cells, which are found in early embryos.

In addition, the establishment of mammalian reproductive cloning has introduced additional possibilities for extending this technology to human cells to create human embryonic stem cells by genome ...

The U.S. Patent and Trademark Office announced Tuesday that it intends to review patents for embryonic stem-cell research held by the Wisconsin Alumni Research Foundation. These patents cover work ...

Stem cell therapies are a safe and effective way of treating Parkinson's disease, according to results of two independent ...